Dr Reddy's Shares Crash On Fresh US FDA Worries

Posted By:

Shares in Dr Reddy's crashed after the US FDA identified significant deviations at the plants of the company it had inspected.

Earlier this month the company was issued a warning letter from the US FDA for these three plants. The stock crashed almost 7 per cent, following new details uploaded by the US FDA. The shares were last trading at Rs 3170, on the National Stock Exchange.

Dr Reddy's Shares Crash On Fresh US FDA Worries
The US FDA has said that company's responses from December 15th, 2014 to March 27th, 2015 lack sufficient corrective actions.

"These deviations and violations cause your APIs and finished drug products to be adulterated within the meaning of Section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 351(a)(2)(B).  The methods used in, or the facilities or controls used for, their manufacture, processing, packing, or holding do not conform to, or are not operated or administered in conformity with, CGMP," the US FDA has said in its warning letter.

"Several violations are recurrent or represent long-standing failures to adequately resolve significant manufacturing quality problems. It is apparent that you have not implemented a robust quality system at your sites," the US FDA has said.  

"Until you complete all corrections and FDA confirms your compliance with CGMP, FDA may withhold approval of any new applications or supplements listing your firm as a drug product or API manufacturer."

GoodReturns.in

Read more about: dr reddys, us fda
Story first published: Thursday, November 26, 2015, 10:11 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?